189 related articles for article (PubMed ID: 11384203)
1. Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala.
Smiałowska M; Bajkowska M; Heilig M; Obuchowicz E; Turchan J; Maj M; Przewłocki R
Neuropeptides; 2001 Apr; 35(2):82-91. PubMed ID: 11384203
[TBL] [Abstract][Full Text] [Related]
2. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats.
Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H
Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379
[TBL] [Abstract][Full Text] [Related]
3. The effect of competitive and non-competitive NMDA receptor antagonists, ACPC and MK-801 on NPY and CRF-like immunoreactivity in the rat brain amygdala.
Wierońska JM; Brański P; Pałvcha A; Smiałowska M
Neuropeptides; 2001; 35(5-6):219-26. PubMed ID: 12030805
[TBL] [Abstract][Full Text] [Related]
4. Reserpine induces increase in neuropeptide Y immunoreactivity in rat amygdala neurons.
Smiałowska M; Bajkowska M
Pol J Pharmacol; 1998; 50(6):443-7. PubMed ID: 10385927
[TBL] [Abstract][Full Text] [Related]
5. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
6. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
[TBL] [Abstract][Full Text] [Related]
7. The corticotropin-releasing factor (CRF)-system and monoaminergic afferents in the central amygdala: investigations in different mouse strains and comparison with the rat.
Asan E; Yilmazer-Hanke DM; Eliava M; Hantsch M; Lesch KP; Schmitt A
Neuroscience; 2005; 131(4):953-67. PubMed ID: 15749348
[TBL] [Abstract][Full Text] [Related]
8. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
Sajdyk TJ; Fitz SD; Shekhar A
Stress; 2006 Mar; 9(1):21-8. PubMed ID: 16753930
[TBL] [Abstract][Full Text] [Related]
9. Regulation of neuropeptide Y gene expression in rat brain.
Lindefors N; Brené S; Herrera-Marschitz M; Persson H
Ann N Y Acad Sci; 1990; 611():175-85. PubMed ID: 1978997
[TBL] [Abstract][Full Text] [Related]
10. In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat.
Compère V; Li S; Leprince J; Tonon MC; Vaudry H; Pelletier G
Brain Res Mol Brain Res; 2005 Nov; 141(2):156-60. PubMed ID: 16154662
[TBL] [Abstract][Full Text] [Related]
11. Effect of uteroplacental insufficiency upon brain neuropeptide Y and corticotropin-releasing factor gene expression and concentrations.
Rajakumar PA; He J; Simmons RA; Devaskar SU
Pediatr Res; 1998 Aug; 44(2):168-74. PubMed ID: 9702909
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
13. Roles of corticotropin-releasing factor, neuropeptide Y and corticosterone in the regulation of food intake in Xenopus laevis.
Crespi EJ; Vaudry H; Denver RJ
J Neuroendocrinol; 2004 Mar; 16(3):279-88. PubMed ID: 15049859
[TBL] [Abstract][Full Text] [Related]
14. Effect of 6-hydroxydopamine on neuropeptide Y and corticotropin-releasing factor expression in rat amygdala.
Smiałowska M; Bajkowska M; Prezewłocka B; Maj M; Turchan J; Przewłocki R
Neuroscience; 1999; 94(4):1125-32. PubMed ID: 10625052
[TBL] [Abstract][Full Text] [Related]
15. [Significance of CRF and dopamine receptors in amygdala for reinforcing effects of opiates and opioids on self-stimulation of lateral hypothalamus in rats].
Shabanov PD; Lebedev AA; Liubimov AV; Kornilov VA
Eksp Klin Farmakol; 2011; 74(7):3-8. PubMed ID: 21894759
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
Huang XF; Tan YY; Huang X; Wang Q
Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of NPY and its receptors in alcohol-preferring AA and alcohol-avoiding ANA rats.
Caberlotto L; Thorsell A; Rimondini R; Sommer W; Hyytiä P; Heilig M
Alcohol Clin Exp Res; 2001 Nov; 25(11):1564-9. PubMed ID: 11707630
[TBL] [Abstract][Full Text] [Related]
18. Long-term losses of amygdala corticotropin-releasing factor neurons are associated with behavioural outcomes following neonatal hypoxia-ischemia.
Carty ML; Wixey JA; Kesby J; Reinebrant HE; Colditz PB; Gobe G; Buller KM
Behav Brain Res; 2010 Apr; 208(2):609-18. PubMed ID: 20085787
[TBL] [Abstract][Full Text] [Related]
19. Altered neuropeptide Y and neurokinin messenger RNA expression and receptor binding in stress-sensitised rats.
de Lange RP; Wiegant VM; Stam R
Brain Res; 2008 May; 1212():35-47. PubMed ID: 18440496
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y activates urocortin 1 neurons in the nonpreganglionic Edinger-Westphal nucleus.
Gaszner B; Korosi A; Palkovits M; Roubos EW; Kozicz T
J Comp Neurol; 2007 Feb; 500(4):708-19. PubMed ID: 17154253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
